Literature DB >> 16927286

Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years.

James W Matheson1, Fenella J Rich, Catherine Cohet, Keith Grimwood, Q Sue Huang, David Penny, Michael D Hendy, Joanna R Kirman.   

Abstract

Respiratory syncytial virus (RSV) is the most important cause of viral lower respiratory tract infections in infants and children worldwide. In New Zealand, infants with RSV disease are hospitalized at a higher rate than other industrialized countries, without a proportionate increase in known risk factors. The molecular epidemiology of RSV in New Zealand has never been described. Therefore, we analyzed viral attachment glycoprotein (G) gene sequences from 106 RSV subgroup A isolates collected in New Zealand between 1967 and 2003, and 38 subgroup B viruses collected between 1984 and 2004. Subgroup A and B sequences were aligned separately, and compared to sequences of viruses isolated from other countries during a similar period. Genotyping and clustering analyses showed RSV in New Zealand is similar and temporally related to viruses found in other countries. By quantifying temporal clustering, we found subgroup B viruses clustered more strongly than subgroup A viruses. RSV B sequences displayed more variability in stop codon usage and predicted protein length, and had a higher degree of predicted O-glycosylation site changes than RSV A. The mutation rate calculated for the RSV B G gene was significantly higher than for RSV A. Together, these data reveal that RSV subgroups exhibit different patterns of evolution, with subgroup B viruses evolving faster than A.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927286     DOI: 10.1002/jmv.20702

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  24 in total

1.  A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype.

Authors:  Alicia Arnott; Sirenda Vong; Sek Mardy; Simon Chu; Monica Naughtin; Ly Sovann; Carole Buecher; Julien Beauté; Sareth Rith; Laurence Borand; Nima Asgari; Roger Frutos; Bertrand Guillard; Sok Touch; Vincent Deubel; Philippe Buchy
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

2.  Investigation of Respiratory Syncytial Virus Outbreak on an Adult Stem Cell Transplant Unit by Use of Whole-Genome Sequencing.

Authors:  Yijun Zhu; Teresa R Zembower; Kristen E Metzger; Zhengdeng Lei; Stefan J Green; Chao Qi
Journal:  J Clin Microbiol       Date:  2017-07-26       Impact factor: 5.948

3.  Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice.

Authors:  Kate L Stokes; Michael H Chi; Kaori Sakamoto; Dawn C Newcomb; Michael G Currier; Matthew M Huckabee; Sujin Lee; Kasia Goleniewska; Carla Pretto; John V Williams; Anne Hotard; Taylor P Sherrill; R Stokes Peebles; Martin L Moore
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

4.  Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.

Authors:  José A Melero; Martin L Moore
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

5.  Direct whole-genome deep-sequencing of human respiratory syncytial virus A and B from Vietnamese children identifies distinct patterns of inter- and intra-host evolution.

Authors:  Lien Anh Ha Do; Andreas Wilm; H Rogier van Doorn; Ha Minh Lam; Shuzhen Sim; Rashmi Sukumaran; Anh Tuan Tran; Bach Hue Nguyen; Thi Thu Loan Tran; Quynh Huong Tran; Quoc Bao Vo; Nguyen Anh Tran Dac; Hong Nhien Trinh; Thi Thanh Hai Nguyen; Bao Tinh Le Binh; Khanh Le; Minh Tien Nguyen; Quang Tung Thai; Thanh Vu Vo; Ngoc Quang Minh Ngo; Thi Kim Huyen Dang; Ngoc Huong Cao; Thu Van Tran; Lu Viet Ho; Jeremy Farrar; Menno de Jong; Swaine Chen; Niranjan Nagarajan; Juliet E Bryant; Martin L Hibberd
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

6.  Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand.

Authors:  K Grimwood; C Cohet; F J Rich; S Cheng; C Wood; N Redshaw; C W Cunningham; N Pearce; J R Kirman
Journal:  Epidemiol Infect       Date:  2008-01-04       Impact factor: 2.451

7.  Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation.

Authors:  Teresa R Johnson; David Rangel; Barney S Graham; Douglas E Brough; Jason G Gall
Journal:  Mol Ther       Date:  2013-06-10       Impact factor: 11.454

8.  Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017 Associated with Emergence of a Genetically Distinct Viral Lineage.

Authors:  Beth K Thielen; Erica Bye; Xiong Wang; Stacene Maroushek; Hannah Friedlander; Sarah Bistodeau; Jaime Christensen; Erik Reisdorf; Meghan H Shilts; Karen Martin; Kathryn Como-Sabetti; Anna K Strain; Patricia Ferrieri; Ruth Lynfield
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 5.226

9.  Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons.

Authors:  Kalina T Zlateva; Leen Vijgen; Nathalie Dekeersmaeker; Cecilia Naranjo; Marc Van Ranst
Journal:  J Clin Microbiol       Date:  2007-07-03       Impact factor: 5.948

10.  Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus.

Authors:  Viviane F Botosso; Paolo M de A Zanotto; Mirthes Ueda; Eurico Arruda; Alfredo E Gilio; Sandra E Vieira; Klaus E Stewien; Teresa C T Peret; Leda F Jamal; Maria I de M C Pardini; João R R Pinho; Eduardo Massad; Osvaldo A Sant'anna; Eddie C Holmes; Edison L Durigon
Journal:  PLoS Pathog       Date:  2009-01-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.